Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 29, 2024Breast Cancer ResearchOpen Access

Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells

View Full Paper
Ask AI
Bookmark
Share

Authors

FCFeng ChiJGJason I. GriffithsANAritro Nath

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chi et al. (2024) studied this question.

synapsesocial.com/papers/68e71cb1b6db643587695ebbhttps://doi.org/10.1186/s13058-024-01808-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract PS2-11-25: Paracrine FGFR activation by stromal signals and its association with immune infiltration in breast cancer2026
  2. 2Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic Perspective2025 · 3 citations
  3. 3Abstract PO2-18-06: Targeting fibroblast growth factor receptor (FGFR1) expression through G-quadruplex stabilization inhibits metastatic breast cancer2024
  4. 4The role and research progress of FGF21 in breast cancer: a review2026
  5. 5FGFR1 suppresses STING-mediated interferon response in endocrine therapy resistant breast cancer2026